A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of ...

When a patient finishes cancer treatment, the majority of cancer treatment facilities encourage them to ring a bell that is ...

A Biden spokeswoman confirmed the former president finished several weeks of radiation therapy treatment Monday.

Former president’s spokesperson confirms Biden “rang the bell,” a tradition in cancer facilities to mark major milestones for patients, at the Philadelphia center.

Former President Biden on Monday finished a round of radiation therapy to treat his aggressive former of prostate cancer, according to a Biden spokesperson. The course lasted several weeks and the ...

A spokesperson for Joe Biden says the former Democratic president has completed several weeks of radiation therapy to treat ...

(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Channing Paller discussing germline and somatic genetic ...

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...